Literature DB >> 23486072

Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey.

Betsy Foxman1, Ryan Muraglia, Jean-Paul Dietz, Jack D Sobel, Julian Wagner.   

Abstract

OBJECTIVE: This study aimed to estimate prevalence of vulvovaginal candidiasis (VVC) and recurring VVC (RVVC).
MATERIALS AND METHODS: An online omnibus survey was administered to 6,010 women aged 16 and older in 6 countries.
RESULTS: We analyzed surveys from 6,000 women. Depending on the country, between 29% and 49% of participating women reported having a health care provider-diagnosed vaginal yeast infection during their lifetime. More than one fifth of women reporting one vaginal yeast infection also reported a 12-month period with 4 or more infections (RVVC) (overall 9%). The cumulative probability of RVVC after an initial vaginal yeast infection was very high. By age 25 years, the probability was 10% for women having had 1 initial yeast infection. By age 50 years, it was 25%.
CONCLUSIONS: The overall rates of VVC and RVVC were high and consistent with previous findings. Results were consistent across countries with the exception of France, which had a lower rate of VVC. This may reflect differences in risk behavior, response to infection, or sampling biases. Recurring VVC is a significant health problem in western countries, and the probability that VVC will progress to RVVC is high.

Entities:  

Mesh:

Year:  2013        PMID: 23486072     DOI: 10.1097/LGT.0b013e318273e8cf

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  80 in total

1.  Serious fungal infections in Korea.

Authors:  K Huh; Y E Ha; D W Denning; K R Peck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-04       Impact factor: 3.267

Review 2.  Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.

Authors:  Sarah Höfs; Selene Mogavero; Bernhard Hube
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

3.  Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).

Authors:  W Mendling; K Friese; I Mylonas; E-R Weissenbacher; J Brasch; M Schaller; P Mayser; I Effendy; G Ginter-Hanselmayer; H Hof; O Cornely; M Ruhnke
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

4.  Progresses in vaginal microflora physiology and implications for bacterial vaginosis and candidiasis.

Authors:  Gary Ventolini
Journal:  Womens Health (Lond)       Date:  2016-05-24

5.  [Longitudinal analysis of vaginal microbiota in women with recurrent vulvovaginal candidiasis].

Authors:  Xiao Ma; Hui-Hua Cai; Yan He; Hui-Min Zheng; Ling Kang; Hong-Wei Zhou; Mu-Biao Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

6.  Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs.

Authors:  Jeniel E Nett; David R Andes
Journal:  Microbiol Spectr       Date:  2015-06

7.  An estimate of the burden of serious fungal diseases in Greece.

Authors:  M N Gamaletsou; M Drogari-Apiranthitou; D W Denning; N V Sipsas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-16       Impact factor: 3.267

8.  Burden of serious fungal infections in Guatemala.

Authors:  N Medina; B Samayoa; D Lau-Bonilla; D W Denning; R Herrera; D Mercado; B Guzmán; J C Pérez; E Arathoon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-27       Impact factor: 3.267

9.  Serious fungal infections in Peru.

Authors:  B Bustamante; D W Denning; P E Campos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-10       Impact factor: 3.267

Review 10.  Development of vaccines for Candida albicans: fighting a skilled transformer.

Authors:  Antonio Cassone
Journal:  Nat Rev Microbiol       Date:  2013-12       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.